Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.
Clarke-Pearson DL, Van Le L, Iveson T, Whitney CW, Hanjani P, Kristensen G, Malfetano JH, Beckman RA, Ross GA, Lane SR, DeWitte MH, Fields SZ.
Clarke-Pearson DL, et al.
J Clin Oncol. 2001 Oct 1;19(19):3967-75. doi: 10.1200/JCO.2001.19.19.3967.
J Clin Oncol. 2001.
PMID: 11579118
Clinical Trial.